Table 2. Correlation between GBS sequence type and clinical syndrome.
| sequence type | Clinical syndrome | ||
|---|---|---|---|
| Colonization isolates n = 32 (%) | IUFD isolates n = 13 (%) | EOD isolates (n = 19) | |
| ST-1 | 13 (40.6) | 7 (53.8) | 1 (5.3) |
| ST- 4 | 0 | 1 (7.7) | 0 |
| ST-6 | 0 | 1 (7.7) | 0 |
| ST-8 | 4 (12.5) | 0 | 0 |
| ST-12 | 1 (3.1) | 0 | 0 |
| ST-17 | 9 (28.1) | 1(7.7) | 14 (73.7) |
| ST-19 | 4 (12.5) | 1 (7.7) | 0 |
| ST-23 | 0 | 0 | 1 (5.3) |
| ST-27 | 0 | 1 (7.7) | 2 (10.5) |
| ST-106 | 0 | 0 | 1 (5.3) |
| ST-196 | 0 | 1 (7.7) | 0 |
| ST-459 | 1 (3.1) | 0 | 0 |
Correlation between GBS sequence type and clinical syndrome colonizing strains (rectovaginal cultures), EOD strains (blood cultures of neonates with EOD) and IUFD strains (fetal remains cultures).
EOD—early onset disease; IUFD—intrauterine fetal death